Medical
MMI said surgeons had used Symani in nearly 1,000 operations in Europe before the US clearance.
A dated step forward on the record · Company-reported
What the source says
“Surgeons have used Symani in nearly 1,000 clinical cases in Europe, plus thousands more in preclinical situations around the world.”
What it means
Symani, from MMI (Medical Microinstruments), is at stage 5 of 5 on our ladder: regulator-cleared or mass market. Its stage is set by other milestones on its record; this one adds to the history. This line rests on the company's own announcement; no regulator, customer or independent report confirms it in our sources yet.
Human help: Our sources report it working without human help.
More on Symani
- Baptist Health in Jacksonville, Florida did the first operation in a US study (REMIND) testing Symani microsurgery for Alzheimer's and similar brain diseases. The study plans 15 patients.
- A new US billing code for lymph-to-vein bypass surgery with robot help (CPT 1019T) was created, taking effect 1 January 2026, so hospitals can bill for these operations.
- Penn Presbyterian Medical Center did the first two US operations with Symani, rebuilding damaged limbs.
- The FDA cleared Symani through the De Novo route (DEN230032) for microsurgery on soft tissue.